Systematic review with meta‐analysis: the efficacy of a second anti‐TNF in patients with inflammatory bowel disease whose previous anti‐TNF treatment has failed

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|41|7|613-623

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.41, Iss.7, 2015-04, pp. : 613-623

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and safety of anti‐TNF therapy in elderly patients with inflammatory bowel disease

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 4, 2015-08 ,pp. : 441-451

John Wiley & Sons Inc

Access to resources Recommend Favorite

Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti‐TNF therapy

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 4, 2015-08 ,pp. : 391-405

John Wiley & Sons Inc

Access to resources Recommend Favorite

Review article: pharmacological aspects of anti‐TNF biosimilars in inflammatory bowel diseases

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 10, 2015-11 ,pp. : 1158-1169

John Wiley & Sons Inc

Access to resources Recommend Favorite

Review article: pharmacological aspects of anti‐TNF biosimilars in inflammatory bowel diseases

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 269-2813, Iss. 10, 2015-11 ,pp. : 1158-1169

John Wiley & Sons Inc

Access to resources Recommend Favorite

Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti‐TNF alpha: 5‐year follow‐up study

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 7, 2015-10 ,pp. : 880-888

John Wiley & Sons Inc

Access to resources Recommend Favorite